KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Non-Current Assets: 2018-2025

Historic Other Non-Current Assets for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Sep 2025 value amounting to $93,000.

  • Aurinia Pharmaceuticals' Other Non-Current Assets fell 89.29% to $93,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $93,000, marking a year-over-year decrease of 89.29%. This contributed to the annual value of $823,000 for FY2024, which is 45.75% down from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Other Non-Current Assets stood at $93,000, which was down 0.00% from $93,000 recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Other Non-Current Assets' 5-year high stood at $13.4 million during Q1 2023, with a 5-year trough of $93,000 in Q2 2025.
  • Over the past 3 years, Aurinia Pharmaceuticals' median Other Non-Current Assets value was $868,000 (recorded in 2024), while the average stood at $2.1 million.
  • In the last 5 years, Aurinia Pharmaceuticals' Other Non-Current Assets surged by 5,572.73% in 2021 and then plummeted by 89.29% in 2025.
  • Aurinia Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $11.8 million in 2021, then increased by 12.68% to $13.3 million in 2022, then crashed by 88.63% to $1.5 million in 2023, then tumbled by 45.75% to $823,000 in 2024, then crashed by 89.29% to $93,000 in 2025.
  • Its Other Non-Current Assets was $93,000 in Q3 2025, compared to $93,000 in Q2 2025 and $823,000 in Q1 2025.